Current Progress of COPD Early Detection: Key Points and Novel Strategies

Abstract

Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity and mortality worldwide, with approximately 70% to 80% of adults with COPD being undiagnosed. Patients with undiagnosed COPD are at increased risk of poor outcomes and a worsened quality of life, making early detection a crucial strategy to mitigate the impact of COPD and reduce the burden on healthcare systems. In the past decade, increased interest has been focused on the development of effective strategies and instrument for COPD early detection. However, identifying undiagnosed cases of COPD is still challenging. Both screening and case-finding approaches have been adopted to identify undiagnosed COPD, with case-finding being recommended by the 2023 Global Initiative for Chronic Obstructive Lung Disease (GOLD) guideline and the updated United States Preventive Services Task Force (USPTF) recommendation. Nonetheless, the approaches, criteria, and instruments used for early detection of COPD are varied. However, advances in the taxonomy and risk factors of COPD are continuously being investigated. It is important to continuously assess the current state of knowledge on COPD early detection, given the challenges associated with identifying undiagnosed COPD. This review aims to highlight recent advances in early detection of COPD. To discuss the current challenge and opportunity in COPD early detection, providing an overview of existing literature on COPD case-finding strategies, including the approaches, criteria for subjects, and instruments. The review also summarizes the current progress in COPD case-findings and proposes a COPD case-finding flowchart as an efficient method for identifying at risk COPD patients.

Polyphenols as Therapeutics in Respiratory Diseases: Moving from Preclinical Evidence to Potential Clinical Applications

“…Shortness of breath is one of the most common symptoms of long-term respiratory issues 48 . Over the last decade, there has been a growing emphasis on the creation of efficient methods and tools for the early identification of COPD 49 . Inflammation caused by COPD has been associated with the risk of lung cancer.…”

Pulmonary Surfactant: A Mighty Thin Film

“…Chronic Obstructive Pulmonary Disease (COPD), or emphysema, represents one of the current leading causes of chronic morbidity and mortality. , While elevated alpha-1 antitrypsin is considered a prototypic biomarker for emphysema, it only accounts for 1–5% of this disease. Many different complex mechanisms underlie the initiation and progression of this multifactorial ailment …”

Exploring Current Concepts and Challenges in the Identification and Management of Early-Stage COPD

“…Firstly, to advance the identification of these types of COPD in the initial stages, and secondly, to validate an agreed-upon definition that has clinical and prognostic relevance. In this sense, various authors have already proposed strategies to make advances in this direction using various instruments, from simple questionnaires or respiratory function tests to complex laboratory techniques [ 61 , 82 , 83 ]. Here, understanding well what the determinants are that influence the more or less symptomatic clinical presentation, before the obstruction appears, the factors that condition the appearance of the obstruction and the impact of modifying some of them would be research questions that should be addressed.…”